AZO vs TSLA

The Advanced Deterministic Scorecard shows a weak Piotroski F-Score of 4/9, indicating marginal financial health, and the absence of an Altman Z-Score limits distress risk assessment. Despite solid profitability metrics like a 16.94% operating margin and 52.15% gross margin, recent earnings declines and negative earnings surprises over the last four quarters raise concerns. Valuation appears stretched relative to peers with a P/E of 25.77, though below sector average, while insider selling and weakening EPS growth temper bullish sentiment. The stock trades significantly above its intrinsic value estimate of $1,004.92, suggesting substantial premium pricing based on growth expectations.

Tesla's deterministic health is marginally stable with a Piotroski F-Score of 4/9, but the valuation is fundamentally decoupled from financial performance. The stock trades at a massive premium to its Graham Number ($23.07) and Intrinsic Value ($7.56), while exhibiting negative revenue growth (-3.10%) and a severe collapse in earnings growth (-60.60%). With zero earnings beats in the last four quarters and bearish insider activity, the current price is supported by sentiment rather than data.